FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897939904> ?p ?o ?g. }

• W2897939904 abstract "Daclizumab is a humanized monoclonal antibody that blocks CD25, the high affinity alpha subunit of the interleukin-2 receptor. Daclizumab therapy targets T regulatory cell and activated effector T cell proliferation to suppress autoimmune disease activity, in inflammatory conditions like relapsing and remitting multiple sclerosis. Here, we present the first report of agranulocytosis with daclizumab therapy in a patient with relapsing and remitting multiple sclerosis. Our patient was a 24-year-old Australian female with a clinical history of atopy, lymphocytic enteritis complicated by B12 deficiency, relapsing and remitting multiple sclerosis, recurrent lower respiratory tract infections, vulval/cervical intraepithelial neoplasia and melanoma. She was commenced on daclizumab therapy after failing several lines of treatment for relapsing and remitting multiple sclerosis. During a hospital admission for lymphocytic enteritis, she was incidentally diagnosed with combined immunodeficiency with hypogammaglobulinaemia and declined proposed regular intravenous immunoglobulin infusions. Following six months of daclizumab therapy, our patient presented to hospital with febrile neutropenia. No clear infective cause was found, despite numerous investigations. However, bone marrow biopsy revealed agranulocytosis with an apparent maturation block at the myeloblasts stage. Neustrophil recovery occurred following cessation of daclizumab and the initiation of T cell immunosuppressive agents including systemic corticosteroids and methotrexate. The patient was further investigated for combined immunodeficiency and whole exome sequencing revealed a novel heterozygous missense variant in cytotoxic T lymphocyte antigen 4 (CTLA4), leading to a diagnosis of CTLA-4 haploinsufficiency with autoimmune infiltration (CHAI). This case demonstrates that autoimmune disease may be the presenting feature of primary immunodeficiency and should be appropriately investigated prior to the commencement of immunotherapy. Genetic clarification of underlying primary immunodeficiency may provide critical clinical information that alters the safety of the proposed treatment strategy." @default.
• W2897939904 created "2018-10-26" @default.
• W2897939904 creator A5002005990 @default.
• W2897939904 creator A5013481031 @default.
• W2897939904 creator A5022048012 @default.
• W2897939904 creator A5036994428 @default.
• W2897939904 creator A5040628515 @default.
• W2897939904 creator A5053786359 @default.
• W2897939904 creator A5058836163 @default.
• W2897939904 creator A5058954646 @default.
• W2897939904 creator A5059113643 @default.
• W2897939904 creator A5065109936 @default.
• W2897939904 creator A5079039581 @default.
• W2897939904 creator A5079436807 @default.
• W2897939904 date "2018-10-22" @default.
• W2897939904 modified "2023-10-17" @default.
• W2897939904 title "Pitfalls of immunotherapy: lessons from a patient with CTLA-4 haploinsufficiency" @default.
• W2897939904 cites W1967067685 @default.
• W2897939904 cites W2049345643 @default.
• W2897939904 cites W2061071534 @default.
• W2897939904 cites W2081255498 @default.
• W2897939904 cites W2149915530 @default.
• W2897939904 cites W2164351607 @default.
• W2897939904 cites W2461116874 @default.
• W2897939904 cites W2471609425 @default.
• W2897939904 cites W2756233837 @default.
• W2897939904 doi "https://doi.org/10.1186/s13223-018-0272-7" @default.
• W2897939904 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6196561" @default.
• W2897939904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30377434" @default.
• W2897939904 hasPublicationYear "2018" @default.
• W2897939904 type Work @default.
• W2897939904 sameAs 2897939904 @default.
• W2897939904 citedByCount "8" @default.
• W2897939904 countsByYear W28979399042018 @default.
• W2897939904 countsByYear W28979399042019 @default.
• W2897939904 countsByYear W28979399042020 @default.
• W2897939904 countsByYear W28979399042021 @default.
• W2897939904 countsByYear W28979399042022 @default.
• W2897939904 crossrefType "journal-article" @default.
• W2897939904 hasAuthorship W2897939904A5002005990 @default.
• W2897939904 hasAuthorship W2897939904A5013481031 @default.
• W2897939904 hasAuthorship W2897939904A5022048012 @default.
• W2897939904 hasAuthorship W2897939904A5036994428 @default.
• W2897939904 hasAuthorship W2897939904A5040628515 @default.
• W2897939904 hasAuthorship W2897939904A5053786359 @default.
• W2897939904 hasAuthorship W2897939904A5058836163 @default.
• W2897939904 hasAuthorship W2897939904A5058954646 @default.
• W2897939904 hasAuthorship W2897939904A5059113643 @default.
• W2897939904 hasAuthorship W2897939904A5065109936 @default.
• W2897939904 hasAuthorship W2897939904A5079039581 @default.
• W2897939904 hasAuthorship W2897939904A5079436807 @default.
• W2897939904 hasBestOaLocation W28979399041 @default.
• W2897939904 hasConcept C126322002 @default.
• W2897939904 hasConcept C159654299 @default.
• W2897939904 hasConcept C203014093 @default.
• W2897939904 hasConcept C2776042228 @default.
• W2897939904 hasConcept C2777037409 @default.
• W2897939904 hasConcept C2777607303 @default.
• W2897939904 hasConcept C2777805810 @default.
• W2897939904 hasConcept C2777832160 @default.
• W2897939904 hasConcept C2779338263 @default.
• W2897939904 hasConcept C2779719350 @default.
• W2897939904 hasConcept C2780653079 @default.
• W2897939904 hasConcept C542903549 @default.
• W2897939904 hasConcept C71924100 @default.
• W2897939904 hasConcept C8891405 @default.
• W2897939904 hasConceptScore W2897939904C126322002 @default.
• W2897939904 hasConceptScore W2897939904C159654299 @default.
• W2897939904 hasConceptScore W2897939904C203014093 @default.
• W2897939904 hasConceptScore W2897939904C2776042228 @default.
• W2897939904 hasConceptScore W2897939904C2777037409 @default.
• W2897939904 hasConceptScore W2897939904C2777607303 @default.
• W2897939904 hasConceptScore W2897939904C2777805810 @default.
• W2897939904 hasConceptScore W2897939904C2777832160 @default.
• W2897939904 hasConceptScore W2897939904C2779338263 @default.
• W2897939904 hasConceptScore W2897939904C2779719350 @default.
• W2897939904 hasConceptScore W2897939904C2780653079 @default.
• W2897939904 hasConceptScore W2897939904C542903549 @default.
• W2897939904 hasConceptScore W2897939904C71924100 @default.
• W2897939904 hasConceptScore W2897939904C8891405 @default.
• W2897939904 hasFunder F4320334705 @default.
• W2897939904 hasIssue "1" @default.
• W2897939904 hasLocation W28979399041 @default.
• W2897939904 hasLocation W28979399042 @default.
• W2897939904 hasLocation W28979399043 @default.
• W2897939904 hasLocation W28979399044 @default.
• W2897939904 hasLocation W28979399045 @default.
• W2897939904 hasOpenAccess W2897939904 @default.
• W2897939904 hasPrimaryLocation W28979399041 @default.
• W2897939904 hasRelatedWork W174827180 @default.
• W2897939904 hasRelatedWork W2038398254 @default.
• W2897939904 hasRelatedWork W2048247360 @default.
• W2897939904 hasRelatedWork W2166360764 @default.
• W2897939904 hasRelatedWork W2342657771 @default.
• W2897939904 hasRelatedWork W2897939904 @default.
• W2897939904 hasRelatedWork W2953139807 @default.
• W2897939904 hasRelatedWork W2997611592 @default.
• W2897939904 hasRelatedWork W3154812925 @default.
• W2897939904 hasRelatedWork W4207014863 @default.
• W2897939904 hasVolume "14" @default.

• next